期刊文献+

高血压患者尿微量蛋白水平与血管内皮功能的关系 被引量:4

下载PDF
导出
摘要 目的观察高血压病患者尿微量蛋白及血管内皮功能的变化关系,探讨其在该病肾损害的意义。方法采用免疫速率散射比浊法检测112例高血压病患者尿微量清蛋白(mAlb)、转铁蛋白(TRF)、α1-微球蛋白(α1-M)、β2-微球蛋白(β2-M),并以放射免疫方法检测各病例血内皮素(ET)及一氧化氮(NO)水平,化学法检测血清肌酐(Cr),同时检测正常组各项指标。结果①与正常对照组比较,高血压病1级组尿mAlb,TRF,α1-M,β2-M及血Cr均无明显升高,而血ET增高,血N0降低(P〈0.05)。②高血压病2级组尿mAlb,TRF,α1-M及血ET明显增高,血N0明显降低(P〈0.01),而β2-M、血Cr差异无统计学显著性意义。⑧高血压病3级组尿mAlb,TRF,α1-M及血ET显著升高;血NO显著降低(P〈0.001),尿β2-M和血Cr明显升高(P〈0.01)。④ET分别与血压、Scr及尿mAIb,TRF,α1-M,β2-M呈正相关,N0分别与血压、Scr及尿mAlb,TRF,α1-M,β2-M呈负相关。结论高血压患者尿微量蛋白与血管内皮功能的变化具有明显关系,提示ET及N0在高血压性肾损害病理生理过程中可能发挥重要作用。
出处 《现代检验医学杂志》 CAS 2010年第1期156-157,共2页 Journal of Modern Laboratory Medicine
  • 相关文献

参考文献7

  • 1Erasmus RT, Okesina B . Mieroalbuninuria in clinic population of type Melanesian diabetics. Relationship to glgeemic control blood plessure and duration of diabetics[J]. Gent Afr Med, 1999,45 (1) : 291-296.
  • 2 王振英,张纪云主编.放射免疫分析与临床[M].北京:中国科技出版社,1995.218~268.
  • 3Bidani AK,Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy[J].Hypertension, 2004,44 (5): 595- 601.
  • 4Takahashi K, Totsune K, Mouri T, Endothelin in chronic renal failure[J]. Nephron, 1994,66(4) : 373- 379.
  • 5Frith TD,Ratctiffe PJ ,Raine AEG ,et al. Endothelin: An important factor in acute renal failure [J]. Lancet,1998,86(21):1179-1182.
  • 6Morrissey JJ,Mccracken K,Kaneto H,et al, Location of an inducible nitric oxide synthase mRNA in the normal kidney [J]. Kidney Int, 1994, 45 (4): 998- 1003.
  • 7Ishmail A,Gary P,Miri Am B,et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production[J]. Kidney Int,1995,47(6):1515-1521.

共引文献13

同被引文献56

  • 1黄文胜,杜礼兵,冷利华.厄贝沙坦对高血压患者尿微量蛋白排泄的影响[J].安徽医学,2009,30(12):1460-1461. 被引量:4
  • 2黄惠玲,孙东升,黄慧芳.老年高血压人群血HCY、尿MAU测定及其临床意义[J].浙江医学,2005,27(3):171-172. 被引量:2
  • 3Cirillo M, Stellato D, Lombardi C, et al. Urinary albumin excretion and coronary artery disease. G Ital Nefrol, 2006, 23 Suppl 34:S11-15.
  • 4de Zeeuw D. Albuminuria, just a marker for cardiovascular disease, or is it more? J Am Soc Nephrol,2005,16: 1883-1885.
  • 5Diercks GF,van Boven A J, Hillege JL, et al. The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol,2002,18:525-535.
  • 6Tsioufis C, Dimitriadis K, Chatzis D, et al. Relation of microalbuminufia to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol, 2005,96: 946-951.
  • 7Yetik, Anacak G, Catravas JD. Nitile oxide and the endotbelium: history and impact on cardiovascular disease. Vascul Pharmacol, 2006,5 (45) : 268-276.
  • 8Chiarelli F ,Cipollone F,Romano F, et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes, 2000,49: 1258-1263.
  • 9Stehouwer CD, Henry RM, Dekker JM, et al. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction-the Hoom Study. Kidney Int Suppl, 2004 (92) : S42-44.
  • 10Levey AS, Coresh J,Balk E, et al. National kidney foundation practice guidelines forchronic kidney disease: evaluation, classification, and stratification. Ann Intern Med, 2003,139 (2) : 137-147.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部